Avalo Therapeutics (AVTX) Raw Materials (2018)

Avalo Therapeutics' (AVTX) quarterly Raw Materials came in at $11392.0 in Q4 2018.

Avalo Therapeutics (AVTX) Raw Materials (2018) Analysis & Trends

Avalo Therapeutics (AVTX) has 1 years of Raw Materials data on file, last reported at $11392.0 in Q4 2018.

Quarterly Raw Materials changed N/A year-over-year to $11392.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $11392.0 (changed N/A YoY) and the FY2018 annual result came in at $11392.0, changed N/A from the prior year.
Raw Materials was little changed at $11392.0 in Q4 2018.
In the past five years, Raw Materials ranged from a high of $11392.0 in Q4 2018 to a low of $11392.0 in Q4 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Avalo Therapeutics	854.16 Mn	453.89 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2018	11,392.00